New patent for Azurity drug KATERZIA

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for KATERZIA
Annual Drug Patent Expirations for KATERZIA

Katerzia is a drug marketed by Azurity and is included in one NDA. It is available from one supplier. There are five patents protecting this drug.

KATERZIA drug price trends.

This drug has ten patent family members in six countries.

The generic ingredient in KATERZIA is amlodipine benzoate. One supplier is listed for this compound. Additional details are available on the amlodipine benzoate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top